- Adma Biologic (Nasdaq:Economy) It is planned to publish the results of earnings in Q4 on Monday, March 3, after the market closure.
- Consensus EPS estimate is $ 0.15 (+287.5% y/y) and the consensus revenue assessment is $ 112.8 million (+52.6% y/y).
- In the last 3 months, EPS estimates have seen 1 upward audit and 0 down. Revenue estimates recorded 1 audit upwards and 0 down.
